Patent US4093677A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4093677A Expired / Lapsed US ⏱️ 0.0 years remaining

Macromolecular materials suitable for forming antithrombogenic prosthesis and artificial organs and process for preparing same

Assignee: Individual
•
Filing: 1977-03-17
•
Granted: 1978-06-06
•
Expires: 1997-03-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel block copolymers suitable to manufacture permanently antithrombogenic prosthetic devices are obtained by first preparing a polyamide-amine prepolymer ##STR1## WHEREIN R 1 and R 2 are alkyl or hydroxy-alkyl radicals with 1-6 carbon atoms, R 3 and R 4 are alkyl radicals with 1-6 carbon atoms, R 5 is an alkenyl radical with 1-12 carbon atoms, or together with R 1 , R 2 and R 3 , R 4 respectively and the nitrogen atoms to which it is linked, it forms an unsubstituted or substituted piperazine ring and then polymerizing at least one monomer suitable to form thermoplastic addition or condensation polymers in the presence of the polyamide-amine prepolymer.

Inventors

  • 👤 Paolo Ferruti
  • 👤 Ezio Martuscelli
  • 👤 Fernando Riva
  • 👤 Luciano Provenzale

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:33
CPC Classifications
C; C08; C08G; C08G69/00; A; A61; A61L; A61L33/00; A61L33/06; A61L33/064; C08F; C08F283/00; C08F283/04

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 26 words
Macromolecular materials suitable for forming antithrombogenic artificial organs characterized in that they are block polymers comprising polyamidic-aminic blocks and blocks from conventional polyaddition or polycondensation polymers.
Claim 2
Dependent Claim 26 words
Macromolecular materials suitable for forming antithrombogenic artificial organs characterized in that they are block polymers comprising polyamidic-aminic blocks and blocks from conventional polyaddition or polycondensation polymers.
Claim 3
Dependent Claim 83 words
Macromolecular materials according to claim 1, wherein the polyamidic-aminic blocks have the structure ##STR12## wherein R 1 and R 2 are alkyl or hydroxy-alkyl radicals with 1-6 carbon atoms, R 3 and R 4 are alkyl radicals with 1-6 carbon atoms, R 5 is an alkenyl radical with 1-12 carbon atoms, or together with R 1 , R 2 and R 3 , R 4 respectively and the nitrogen atoms to which it is linked, it forms an unsubstituted or substituted piperazine ring.
Claim 4
Dependent Claim 65 words
Macromolecular materials according to claim 1, wherein the polyamidic-aminic blocks have the structure ##STR13## wherein R 1 , R 3 and R 4 are alkyl radicals with 1-6 carbon atoms, R 5 is an alkenyl radical with 1-12 carbon atoms, or together with R 3 , R 4 and the nitrogen atoms to which it is linked, it forms an unsubstituted or substituted piperazine ring.
Claim 5
Dependent Claim 43 words
Macromolecular materials according to claim 1, wherein the polyamidic-aminic blocks also comprise other monomers preferably selected from the group consisting of piperazine mono- and di-carboxylic acids, aliphatic amino-acids having 1-6 carbon atoms, allyl-amine and primary di-amines having from 2 to 12 carbon atoms.
Claim 6
Dependent Claim 18 words
Macromolecular materials according to claim 1, wherein the polyamidic-aminic blocks have end groups of the following kind ##STR14##
Claim 7
Dependent Claim 28 words
Macromolecular materials according to claim 1, wherein the polyamidic-aminic blocks have end group of the following kind ##STR15## wherein R 1 and R 5 are as before defined.
Claim 8
Dependent Claim 31 words
Macromolecular materials according to claim 1, wherein the conventional polymer blocks are polyvinyl or polyvinylidene polyaddition polymers preferably selected from the group consisting of polystyrenes, polyacrylates, polymethacrylates, polyacrylamides, polyacrylonitrile and polyvinylacetate.
Claim 9
Dependent Claim 26 words
Macromolecular materials according to claim 1, wherein the conventional polymer blocks are polycondensation polymers preferably selected from the group consisting of polyamides, polyureas, polyurethanes and polyesters.
Claim 10
Dependent Claim 128 words
A process for preparing macromolecular materials suitable for forming antithrombogenic prostheses and artificial organs, which comprises: (a) preparing a polyamidic-aminic prepolymer by polyaddition of amines having the formula ##STR16## to bis-acrylamides having the formula ##STR17## wherein R 1 and R 2 are alkyl or hydroxy-alkyl radicals with 1-6 carbon atoms, R 3 and R 4 are alkyl radicals with 1-6 carbon atoms, R 5 is an alkenyl radical with 1-12 carbon atoms, or together with R 1 , R 2 and R 3 , R 4 respectively, and the nitrogen atoms to which it is linked, it forms and unsubstituted or substituted piperazine ring; (b) polymerizing a monomer or a mixture of monomers suitable to form thermoplastic polyaddition or polycondensation polymers in the presence of said polyamidic-aminic prepolymer.
Claim 11
Dependent Claim 128 words
A process for preparing macromolecular materials suitable for forming antithrombogenic prostheses and artificial organs, which comprises: (a) preparing a polyamidic-aminic prepolymer by polyaddition of amines having the formula ##STR16## to bis-acrylamides having the formula ##STR17## wherein R 1 and R 2 are alkyl or hydroxy-alkyl radicals with 1-6 carbon atoms, R 3 and R 4 are alkyl radicals with 1-6 carbon atoms, R 5 is an alkenyl radical with 1-12 carbon atoms, or together with R 1 , R 2 and R 3 , R 4 respectively, and the nitrogen atoms to which it is linked, it forms and unsubstituted or substituted piperazine ring; (b) polymerizing a monomer or a mixture of monomers suitable to form thermoplastic polyaddition or polycondensation polymers in the presence of said polyamidic-aminic prepolymer.
Claim 12
Dependent Claim 21 words
A process according to claim 9, which comprises copolymerizing a polyamidic-aminic prepolymer having vinyl end groups with vinyl or vinylidene monomers.
Claim 13
Dependent Claim 29 words
A process according to claim 9, which comprises copolymerizing a polyamidic-aminic prepolymer having aminic end groups with a mixture of monomers suitable to form step polycondensation or polyaddition polymers.
Claim 14
Dependent Claim 38 words
A process according to claim 9, which comprises carrying out step (a) in water or an hydroxylated organic solvent, at temperatures of from 10° to 50° C, the reaction time varying from a few hours to some days.
Claim 15
Dependent Claim 33 words
A process according to claim 9, which comprises carrying out step (b) under polymerization conditions peculiar to the polymerization of monomers or mixtures of monomers suitable to form polyaddition or polycondensation thermoplastic polymers.
Claim 16
Dependent Claim 31 words
An antithrombogenic article useful in the biomedical field consisting of block macromolecular materials comprising polyamidic-aminic blocks and blocks of conventional poliaddition or polycondensation polymers, the surface of said materials being heparinized.
Claim 17
Dependent Claim 31 words
An antithrombogenic article useful in the biomedical field consisting of block macromolecular materials comprising polyamidic-aminic blocks and blocks of conventional poliaddition or polycondensation polymers, the surface of said materials being heparinized.
Claim 18
Dependent Claim 52 words
A process for manufacturing antithrombogenic articles according to claim 14, which comprises thermoforming said block macromolecular material comprising poliamidicaminic blocks and blocks of conventional polyaddition or polycondensation polymers by extrusion, molding and the like and heparinizing the surfaces thereof by immersing the articles in an aqueous, alcoholic or hydroalcoholic solution of heparin.
Claim 19
Dependent Claim 25 words
A process according to claim 15, wherein the heparin solution has concentration of from 0.1 and 20% and pH value of from 0 to 9.

References Cited (Backward Citations)

US3668278A Cited
US3773739A Cited
US3766138A Cited
US3865723A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-06-05 1981-12-05 1982-06-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-06-05 1985-12-05 1986-06-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-06-05 1989-12-05 1990-06-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag